Skip to main content
SpringerLink
Log in

Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors

  • Preclinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Fourteen patients with acute leukemia in relapse were treated with difluoromethylornithine (DFMO) alone or in combination with methylglyoxal-bis(guanylhydrazone) (MGBG) as part of Phase I studies. Five patients included in the trial exhibited morphologic evidence of cellular differentiation during the course of treatment. In one patient who exhibited no blasts and a normal white blood cell differential at the end of treatment the mononuclear cell content of all three polyamines declined after an initial increase in spermidine and spermine content. In the other patients in whom the cellular maturation was less pronounced the mononuclear cell polyamine levels remained stable or increased over the treatment time. No absolute difference was apparent between the cellular polyamine levels detected in patients at the times of the greatest increase in per cent circulating neutrophils as compared to the cellular levels present in patients whose circulating mononuclear cell number were increasing. Circulating mononuclear cell putrescine, spermidine, and spermine levels varied over two orders of magnitude from patient to patient and the range of values detected in each state completely overlapped those present in the other. It does not appear from the present study that there is a consistent human leukemic cell polyamine content at which cellular differentiation occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243 (Cell Physiol) 12:C212–221, 1982

    Google Scholar 

  2. Tabor CW, Tabor H: Polyamines. Ann Rev Biochem 53:749–790, 1984

    Google Scholar 

  3. Luk GD, Sharkis SJ, Abeloff MD, McCann PP, Sjoerdsma A, Baylin SB: Polyamine biosynthesis is required for the maintenance of peripheral blood cell elements in the rat. Proc Nat1 Acad Sci USA 80:5090–5093, 1983

    Google Scholar 

  4. Mamont PS, Duschesne M-C, Grove J, Bey P: Antiproliferative properties of DL-alpha-difluoromethylornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81:58–66, 1978

    Google Scholar 

  5. Sjoerdsma A, Schechter PJ: Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharm Therap 35:287–300, 1984

    Google Scholar 

  6. Luk GD, Civin CI, Weissman RM, Baylin SB: Ornithine decarboxylase: essential in proliferation but not differentiation of human promyelocytic leukemia cells. Science 216:76–77, 1982

    Google Scholar 

  7. Prakash NJ, Schechter PJ, Grove J, Koch-Weser J: Effect of difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice. Cancer Res 38:3059–3062, 1978

    Google Scholar 

  8. Sugiura M, Shafman T, Kufe D: Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells. Cancer Res 44:1440–1444, 1984

    Google Scholar 

  9. Sugiura M, Shafman T, Mitchell T, Griffin J, Kufe D: Involvement of spermidine in proliferation and differentiation of human promyelocytic leukemia cells. Blood 63:1153–1158, 1984

    Google Scholar 

  10. Heby O, Luk GD, Schindler J: Polyamine synthesis inhibitors act as both inducers and suppressors of cell differentiation. In: McCann PP, Pegg AE, Sjoerdsma A (eds) Inhibition of Polyamine Metabolism. Academic Press, Orlando, 1987, pp 165–183

    Google Scholar 

  11. Gazitt Y, Friend C: Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells. Cancer Res 40:1717–1732, 1980

    Google Scholar 

  12. Huberman E, Weeks C, Herrmann A, Callihan M, Slaga T: Alterations in polyamine levels induced by phorbol diesters and agents that promote differentiation in human promyelocytic leukemia cells. Proc Natl Acad Sci USA 78:1062–1066, 1981

    Google Scholar 

  13. Kufe DW, Griffin J, Mitchell T, Shafman T: Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester. Cancer Res 44:4281–4284, 1984

    Google Scholar 

  14. Watanabe T, Shafman T, Kufe DW: Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells. J Cell Physiol 122:435–440, 1985

    Google Scholar 

  15. Verma DS, Sunkara PS: An essential role for polyamine biosynthesis during human granulopoietic differentiation. Cancer Res 42:3046–3049, 1982

    Google Scholar 

  16. Heby O, Oredsson SM, Olsson I, Marton LJ: A role for the polyamines in mouse embryonal carcinoma (F9 and PCC3) cell differentiation but not in human promyelocytic leukemia (HL-60) cell differentiation. In: Bachrach U, Kaye A and Chazen R, (eds) Advances in Polyamine Research. New York, Raven Press, vol 4, pp. 727–742, 1983

    Google Scholar 

  17. Sharkis SJ, Luk GD, Collector MI, McCann PP, Baylin SB, Sensenbrenner LL: Regulation of hematopoiesis II: The role of polyamine inhibition on helper or suppressor influences of the thymus. Blood 61:604–607, 1983

    Google Scholar 

  18. Metcalf B, Bey P, Danzin C, Jung M, Casara P, Vevert J: Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J Am Chem Soc 100:2551–2553, 1978

    Google Scholar 

  19. Marton LJ, Levin VA, Hervatin SJ, Koch-Weser J, McCann PP, Sjoerdsma A: Potentiation of the therapeutic effects of 1, 3-bis(2-chloroethyl-1-nitrosourea) by difluoromethylornithine, a polyamine biosynthesis inhibitor. Cancer Res 41:4426–4431, 1981

    Google Scholar 

  20. Sunkara PS, Flower SA, Nishioka K, Rao PN: Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine potentiates the cytotoxic effects of arabinosyl cytosine in HELA cells. Biochem Biophys Res Commun 95:423–430, 1980

    Google Scholar 

  21. Corti A, Dave C, Williams-Ashman HG, Mihich E, Schenone A: Specific inhibition of the enzymatic decarboxylase of 5-adenosyl-methionine by methylglyoxal bis(guanylhydrazone) and related substances. Biochem J 139:351–357, 1974

    Google Scholar 

  22. Mikles-Robertson F, Feuerstein B, Dave C, Porter CW: The generality of methylglyoxal bis(guanylhydrazone)-induced mitochondrial damage and the dependence of this effect on cell proliferation. Cancer Res 39:1919–1926, 1979

    Google Scholar 

  23. Warrell Jr RP, Burchenal JH: Methylglyoxal-bis[guanylhydrazone] (Methyl GAG): Current status and future prospects. J Clin Oncol 1:52–65, 1983

    Google Scholar 

  24. Alhonen-Hongisto L, Seppanen P, Janne J: Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis-(guanylhydrazone). Biochem J 192:941–945, 1980

    Google Scholar 

  25. Seppanen P, Alhonen-Hongisto L, Janne J: Death of tumor cells in response to the use of a system of stimulated polyamine uptake for the transport of methylglyoxal bis(guanylhydrazone). Eur J Biochem 118:571–576, 1981

    Google Scholar 

  26. Seppanen P, Alhonen-Hongisto L, Janne J: Polyamine deprivation induced enhanced uptake of methylglyoxal bis (guanylhydrazone) by tumor cells. Biochem Biophys Acta 674:169–177, 1981

    Google Scholar 

  27. Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB: Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine — An inhibitor of polyamine biosynthesis. J Clin Oncol 2:124–130, 1984

    Google Scholar 

  28. Maddox AM, Keating MJ, McCredie KE, Estey E, Freireich EJ: Phase I evaluation of intravenous difluoromethylornithine — A polyamine inhibitor. Invest New Drugs 3:59–64, 1985

    Google Scholar 

  29. Siimes M, Seppanen P, Alhonen-Hongisto L, Janne J: Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemia. Int J Cancer 28:567–570, 1981

    Google Scholar 

  30. Warrell RP, Coonley CJ, Burchenal JH: Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl GAG [methylglyoxal-bis(guanylhydrazone)]. Cancer Chemother Pharmacol 11:134–136, 1983

    Google Scholar 

  31. Durie BGM, Salmon SE, Russell DH: Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 37:214–221, 1977

    Google Scholar 

  32. Horn Y, Beal SL, Walach M, Lubich WP, Spigel L, Marton LJ: Further evidence for the use of polyamines as biochemical markers for malignant tumors. Cancer Res 42: 3248–3251, 1981

    Google Scholar 

  33. Russell DH: Clinical relevance of polyamines. CRC Cri Rev Clin Laborat Sci 18:261–311, 1982

    Google Scholar 

  34. Rath NC, Reddi AH: Changes in polyamines, RNA synthesis, and cell proliferation during matrix-induced cartilage, bone, and bone marrow development. Dev Biol 82:211–216, 1981

    Google Scholar 

  35. Takano T, Takigawa M, Suzuki F: Role of polyamines in expression of the differentiated phenotype of chondrocytes in culture. Med Biol 59:423–427, 1981

    Google Scholar 

  36. Ewton DZ, Erwin BG, Pegg AE, Florini JR: The role of polyamines in stomatomedin-stimulated differentiation of L6 myoblasts. J Cell Physiol 120:263–270, 1984

    Google Scholar 

  37. Erwin BG, Ewton DZ, Florini JR, Pegg AE: Polyamin depletion inhibits the differentiation of L6 myoblast cells. Biochem. Biophys. Res Commun 114:944–949, 1983

    Google Scholar 

  38. Bethell DR, Pegg AE: Polyamines are needed for differentiation of 3T3-L1 fibroblasts into adipose cells. Biochem Biophys Res Commun 102:272–278, 1981

    Google Scholar 

  39. Luk G, Marton L, Baylin S: Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210:195–198, 1980

    Google Scholar 

  40. Emanuelsson H, Heby O: Inhibition of putrescine synthesis blocks development of the polychete Ophryotrocha labronica at gastrulation. Proc Natl Acad Sci USA 75:1039–1042, 1978

    Google Scholar 

  41. Fozard J, Part M-L, Prakash N, Grove J, Schechter P, Sjoerdsma A, Koch-Weser J: L-ornithine decarboxylase: An essential role in early mammalian embryogenesis. Science 208:505–508, 1980

    Google Scholar 

  42. Jetten AM, Shirley JE: Inhibition of ornithine decarboxylase by retinoic acid and difluoromethylornithine in relation to their effects on differentiation and proliferation. Exp Cell Res 156:221–230, 1985

    Google Scholar 

  43. Schindler J, Kelly M, McCann PP: Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation. Biochem Biophys Res Commun 11:410–417, 1983

    Google Scholar 

  44. Schindler J, Kelly M, McCann PP: The response of several murine embryonal carcinoma cell lines to stimulation of differentiation by alpha-difluoromethylornithine. J Cell Physiol 122:1–6, 1985

    Google Scholar 

  45. Chen KY, Nau D, Liu A Y-C: Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells. Cancer Res 43:2812–2818, 1983

    Google Scholar 

  46. Kapyaho K, Sinervirta R, Janne J: Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells. Cancer Res 45:1444–1448, 1983

    Google Scholar 

  47. Sunkara PS, Chang CC, Prakash NJ, Lachmann, PJ: Effect of inhibition of polyamine biosynthesis by DL-alphadifluoromethyl-ornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo. Cancer Res 45:4067–4070, 1985

    Google Scholar 

  48. Proctor MS, Liu S-C, Wilkinson DI: Effect of methylglyoxal bis(guanylhydrazone) on polyamine biosynthesis, growth and differentiation of cultured keratinocytes. Arch Dermatol Res 269:61–68, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, The University of Texas Medical School at Houston, Houston, USA

    Anne-Marie Maddox

  2. Division of Pharmacology, The University of Texas Medical School at Houston, Houston, USA

    Mari K Haddox

  3. Department of Hematology, M.D. Anderson Hospital and Tumor Institute, USA

    Anne-Marie Maddox, Michael J. Keating, Emil J. Freireich & Mari K Haddox

Authors
  1. Anne-Marie Maddox
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Keating
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emil J. Freireich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mari K Haddox
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maddox, AM., Keating, M.J., Freireich, E.J. et al. Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors. Invest New Drugs 7, 119–129 (1989). https://doi.org/10.1007/BF00170848

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00170848

Key words

Search

Navigation